Working... Menu

Liraglutide 3 mg for Knee Osteoarthritis (LOSEIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02905864
Recruitment Status : Completed
First Posted : September 19, 2016
Last Update Posted : March 25, 2019
Novo Nordisk A/S
Cambridge Weight Plan Limited
Information provided by (Responsible Party):
Henrik Gudbergsen, Parker Research Institute